Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6

  1. de Jong, J.
  2. Mitselos, A.
  3. Jurczak, W.
  4. Cordoba, R.
  5. Panizo, C.
  6. Wrobel, T.
  7. Dlugosz-Danecka, M.
  8. Jiao, J.
  9. Sukbuntherng, J.
  10. Ouellet, D.
  11. Hellemans, P.
Revue:
Pharmacology Research and Perspectives

ISSN: 2052-1707

Année de publication: 2020

Volumen: 8

Número: 5

Type: Article

DOI: 10.1002/PRP2.649 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus